NCT06576401View on ClinicalTrials.gov

A Study To Characterize Mass Balance Of [14C] HDM1002 in Chinese Healthy Subjects

PHASE1RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 27, 2024

Primary Completion Date

October 31, 2024

Study Completion Date

December 31, 2024

Conditions
Healthy Adult Subject
Interventions
DRUG

[14C] HDM1002

Administered orally

Trial Locations (1)

Unknown

RECRUITING

The First Affiliated Hospital of Soochow University, Suzhou

All Listed Sponsors
lead

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

INDUSTRY